KRYSTAL BIOTECH INC (KRYS) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:KRYS • US5011471027

278.015 USD
-1.32 (-0.47%)
Last: Jan 30, 2026, 10:24 AM
Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to KRYS. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 269.93. This target is -2.91% below the current price.
  • KRYS was analyzed by 18 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about KRYS.
  • In the previous month the buy percentage consensus was at a similar level.
  • KRYS was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
KRYS Historical Analyst RatingsKRYS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -98 -89 -80 -71 -62 -53 -44 -35 -26 -17 -8 5 10 15

Price Target & Forecast

Price Low Median Mean High 278.02208.06293.76269.93336.00 - -25.16% 5.66% -2.91% 20.86%
KRYS Current Analyst RatingKRYS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2026-01-22 B of A Securities Maintains Buy -> Buy
2026-01-12 Citigroup Maintains Buy -> Buy
2026-01-09 TD Cowen Maintains Buy -> Buy
2026-01-09 Citigroup Maintains Buy -> Buy
2026-01-09 HC Wainwright & Co. Reiterate Buy -> Buy
2026-01-06 Citigroup Upgrade Neutral -> Buy
2025-11-04 Chardan Capital Maintains Buy -> Buy
2025-11-04 Citigroup Maintains Neutral -> Neutral
2025-10-17 B of A Securities Maintains Buy -> Buy
2025-09-15 HC Wainwright & Co. Reiterate Buy -> Buy
2025-08-22 Chardan Capital Maintains Buy -> Buy
2025-08-22 HC Wainwright & Co. Reiterate Buy -> Buy
2025-08-05 Chardan Capital Maintains Buy -> Buy
2025-08-05 Citigroup Maintains Neutral -> Neutral
2025-07-25 Chardan Capital Maintains Buy -> Buy
2025-07-25 HC Wainwright & Co. Reiterate Buy -> Buy
2025-07-22 B of A Securities Maintains Buy -> Buy
2025-07-10 Citigroup Maintains Neutral -> Neutral
2025-07-01 Clear Street Initiate Buy
2025-06-24 HC Wainwright & Co. Reiterate Buy -> Buy
2025-05-16 Citigroup Maintains Neutral -> Neutral
2025-05-07 Chardan Capital Maintains Buy -> Buy
2025-05-07 Guggenheim Maintains Buy -> Buy
2025-05-06 HC Wainwright & Co. Reiterate Buy -> Buy
2025-04-29 HC Wainwright & Co. Maintains Buy -> Buy
2025-04-28 HC Wainwright & Co. Maintains Buy -> Buy
2025-03-05 Jefferies Initiate Buy
2025-02-28 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-20 Chardan Capital Maintains Buy -> Buy
2025-02-20 Cantor Fitzgerald Reiterate Overweight -> Overweight

KRYSTAL BIOTECH INC / KRYS FAQ

What do analysts expect the price target to be for KRYSTAL BIOTECH INC (KRYS)?

18 analysts have analysed KRYS and the average price target is 269.93 USD. This implies a price decrease of -2.91% is expected in the next year compared to the current price of 278.015.


What is the consensus rating for KRYS stock?

The consensus rating for KRYSTAL BIOTECH INC (KRYS) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts cover KRYSTAL BIOTECH INC (KRYS) stock?

The number of analysts covering KRYSTAL BIOTECH INC (KRYS) is 18.